![](/img/cover-not-exists.png)
PRS14 RISK-BENEFIT ASSESSMENT OF TELITHROMYCIN FOR THE TREATMENT OF CAP USING QUALITY-ADJUSTED DAYS (QAD) LOST
LJ McGarry, R Iskandar, L Calimeris, WS Dai, JH Wu, MC WeinsteinVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)62863-x
File:
PDF, 62 KB
english, 2005